<DOC>
	<DOCNO>NCT01443208</DOCNO>
	<brief_summary>To evaluate pharmacokinetics safety single dose multiple dos desvenlafaxine Korean healthy subject compare westerner .</brief_summary>
	<brief_title>Pharmacokinetics Safety Desvenlafaxine Korean Healthy Subjects Following Single Multiple Oral Doses Desvenlafaxine Succinate Sustained Release Tablet</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Desvenlafaxine Succinate</mesh_term>
	<criteria>Healthy male and/or female subject Between age 18 55 year , inclusive Body Mass Index ( BMI ) 17.5 30.5 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) Elevated risk suicide , opinion investigator expert consultant Pregnant nursing female Females childbearing potential unwilling unable use acceptable method contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>pharmacokinetics</keyword>
	<keyword>safety</keyword>
	<keyword>desvenlafaxine</keyword>
	<keyword>Korean healthy subject</keyword>
</DOC>